Joakim Dillner, MD, PhD, Professor of infectious disease epidemiology at the Karolinska Institutet since 2009, Head of the Center for Cervical Cancer Elimination at the Karolinska University Hospital since 2014 and Director of Research & Development at Medical Diagnostics Karolinska, Karolinska University Hospital since 2017. Since 1989, his group has conducted Human Papillomavirus (HPV) research in the areas of molecular biology, immunology and vaccinology, clinical virology and epidemiology.
Major ongoing projects include;
Swedescreen, the first started randomised trial of HPV-screening (since 1997),
Biobank- and registry-based follow-up studies of HPV vaccination (since 1999)
The International Papillomavirus Reference Center (www.hpvcenter.se)
The National Quality Registry of Cervical Cancer Prevention and the Nordic Information for Action eScience Center of Excellence (www.nordicehealth.se)
RISCC - Risk-based Screening for Cervical Cancer (RISCC Risk-based Screening for Cervical Cancer (riscc-h2020.eu))
Updated: November 2023